- Home
- DOMH vs AMIX Comparison
DOMH vs AMIX Comparison
Compare DOMH & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- AMIX
- Stock Information
- Founded
- DOMH 1967
- AMIX 2014
- Country
- DOMH United States
- AMIX United States
- Employees
- DOMH N/A
- AMIX N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- DOMH Health Care
- AMIX
- Exchange
- DOMH Nasdaq
- AMIX NYSE
- Market Cap
- DOMH 8.8M
- AMIX 7.3M
- IPO Year
- DOMH N/A
- AMIX N/A
- Fundamental
- Price
- DOMH $1.35
- AMIX $3.21
- Analyst Decision
- DOMH
- AMIX
- Analyst Count
- DOMH 0
- AMIX 0
- Target Price
- DOMH N/A
- AMIX N/A
- AVG Volume (30 Days)
- DOMH 70.1K
- AMIX 971.1K
- Earning Date
- DOMH 11-08-2024
- AMIX 02-11-2025
- Dividend Yield
- DOMH N/A
- AMIX N/A
- EPS Growth
- DOMH N/A
- AMIX N/A
- EPS
- DOMH N/A
- AMIX N/A
- Revenue
- DOMH $12,589,000.00
- AMIX N/A
- Revenue This Year
- DOMH N/A
- AMIX N/A
- Revenue Next Year
- DOMH N/A
- AMIX N/A
- P/E Ratio
- DOMH N/A
- AMIX N/A
- Revenue Growth
- DOMH 1117.50
- AMIX N/A
- 52 Week Low
- DOMH $0.83
- AMIX $2.55
- 52 Week High
- DOMH $3.20
- AMIX $152.00
- Technical
- Relative Strength Index (RSI)
- DOMH 55.06
- AMIX 43.28
- Support Level
- DOMH $1.00
- AMIX $2.55
- Resistance Level
- DOMH $1.29
- AMIX $3.23
- Average True Range (ATR)
- DOMH 0.12
- AMIX 0.40
- MACD
- DOMH 0.05
- AMIX 0.19
- Stochastic Oscillator
- DOMH 84.21
- AMIX 41.51
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.